Testing effectiveness (Phase 2)Study completedNCT00403429What this trial is testingMITO-6: Capecitabine in Platinum Resistant Ovarian CancerWho this might be right forOvarian Cancer National Cancer Institute, Naples 36
Early research (Phase 1)Study completedNCT02161770What this trial is testingStudy to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver ImpairmentWho this might be right forSolid Tumours AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT00006051What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer UNICANCER
Large-scale testing (Phase 3)Study completedNCT01740427What this trial is testingPalbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)Who this might be right forBreast Neoplasms Pfizer 666
Testing effectiveness (Phase 2)Study completedNCT01423851What this trial is testingSafety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MFWho this might be right forPrimary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis NS Pharma, Inc. 77
Not applicableStudy completedNCT03988959What this trial is testingSurgical Management of Multiple Mucoepidermoid Carcinoma and AdenocarcinomaWho this might be right forAdenocarcinoma; Mucoepidermoid Carcinoma Ain Shams University 7
Testing effectiveness (Phase 2)Study completedNCT01084083What this trial is testingInduction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx CancerWho this might be right forHead and Neck CancerPrecancerous Condition Eastern Cooperative Oncology Group 90
Early research (Phase 1)Study completedNCT02412722What this trial is testingA Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic MalignanciesWho this might be right forNon-hematologic Malignancy Millennium Pharmaceuticals, Inc. 61
Not applicableStudy completedNCT06471270What this trial is testingValidation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian PopulationWho this might be right forOral Cancer British University In Egypt 100
Testing effectiveness (Phase 2)Study completedNCT00818441What this trial is testingDacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The LungWho this might be right forCarcinoma, Non-small Cell Pfizer 119
Not applicableUnknownNCT04163029What this trial is testingOral Care Study of Postoperative InfectionsWho this might be right forCancer, Mouth University of Liege 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03781986What this trial is testingAPG-115 in Salivary Gland Cancer TrialWho this might be right forMalignant Salivary Gland CancerSalivary Gland Cancer University of Michigan Rogel Cancer Center 41
Large-scale testing (Phase 3)UnknownNCT06128694What this trial is testingEffect of NUTRICAN to Improve Nutritional Status in Cancer PatientsWho this might be right forMalnutrition; ProteinCancer, LungCancer Cervix Kalbe International Pte. Ltd 108
Testing effectiveness (Phase 2)Ended earlyNCT02811159What this trial is testingAn Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine FibroidsWho this might be right forUterine Fibroids Repros Therapeutics Inc. 20
Testing effectiveness (Phase 2)Study completedNCT04477486What this trial is testingStudy to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma (MCL) AbbVie 13
Early research (Phase 1)Study completedNCT04648254What this trial is testingOral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid TumorWho this might be right forSolid TumorAdvanced CancerMetastatic Cancer Qurient Co., Ltd. 51
Not applicableActive Not RecruitingNCT02984410What this trial is testingStudy Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal CarcinomaWho this might be right forOropharyngeal CancerSupraglottic Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma European Organisation for Research and Treatment of Cancer - EORTC 112
Early research (Phase 1)Study completedNCT03726294What this trial is testingA Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced CancerWho this might be right forMalignant Neoplasm NatureWise Biotech & Medicals Corporation 33
Early research (Phase 1)Study completedNCT01155713What this trial is testingBioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid TumorsWho this might be right forNeoplasmCancerTumors Novartis Pharmaceuticals 63
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57